Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects (French, HTML)

View metadata and access the original French HTML file: Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects.

Format

HTML

Access

file-only

Publisher-reported update

2024-05-09

Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by injection) fluoroquinolone drugs. The FDA review showed that there were persistent (lasting 30 days or longer after stopping use of fluoroquinolones) and disabling side effects linked to the use of fluoroquinolone products.

Access original file